V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280003160 | 280002386 | 1.8 | null | Curative (C) | 2018-01-07 | 2018-01-11 | Cetuximab + Radiotherapy Load | N | N | 280025093 | CETUXIMAB + RT |
| 280003161 | 280002387 | null | 100 | Curative (C) | 2017-04-10 | 2017-04-10 | Cetuximab + Radiotherapy Load | 02 | null | 280025095 | CETUXIMAB + RT |
| 280003162 | 280007245 | 1.92 | 78.5 | Curative (C) | 2013-08-09 | 2013-08-19 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025096 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003163 | 280002388 | 1.5 | 128 | Neo-adjuvant (N) | 2015-05-26 | 2015-05-27 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025097 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003164 | 280007246 | 1.9 | 102.5 | Palliative (P) | 2016-11-01 | 2016-11-21 | Doxorubicin + Ifosfamide | 02 | N | 280025101 | DOXORUBICIN + IFOSFAMIDE |
| 280003165 | 280002389 | 1.7 | 122 | Adjuvant (A) | 2016-08-29 | 2016-09-04 | Doxorubicin + Ifosfamide | N | N | 280025102 | DOXORUBICIN + IFOSFAMIDE |
| 280003166 | 280002389 | 1.59 | 77 | Curative (C) | 2017-05-06 | 2017-05-16 | Cetuximab + Radiotherapy Load | 2 | N | 280025102 | CETUXIMAB + RT |
| 280003167 | 280002390 | 1.77 | 78.2 | Curative (C) | 2015-04-15 | 2015-05-05 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025104 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003168 | 280002390 | 1.7 | 118.8 | Neo-adjuvant (N) | 2017-04-24 | 2017-05-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025104 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003169 | 280002391 | 1.58 | 78.3 | Curative (C) | 2017-11-04 | 2017-12-07 | CETUXIMAB + RT | N | Y | 280025106 | CETUXIMAB + RT |
| 280003170 | 280002391 | 1.62 | 67.3 | Neo-adjuvant (N) | 2017-10-12 | 2017-10-13 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025106 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003171 | 280002392 | 1.65 | 78.8 | Neo-adjuvant (N) | 2013-11-26 | 2013-11-27 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280025112 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003172 | 280002393 | 1.71 | 86.05 | Curative (C) | 2014-08-19 | 2014-09-17 | CETUXIMAB + RT | N | N | 280025115 | CETUXIMAB + RT |
| 280003173 | 280002394 | 1.74 | 102 | Adjuvant (A) | 2014-06-28 | 2014-07-03 | Doxorubicin + Ifosfamide | 01 | N | 280025117 | DOXORUBICIN + IFOSFAMIDE |
| 280003174 | 280002395 | 1.71 | 75.1 | Curative (C) | 2015-09-17 | 2015-09-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025118 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003175 | 280002395 | 1.6 | 87.8 | Neo-adjuvant (N) | 2016-01-01 | 2016-01-05 | Doxorubicin + Ifosfamide | 02 | N | 280025118 | DOXORUBICIN + IFOSFAMIDE |
| 280003176 | 280002395 | 1.55 | 89.25 | Neo-adjuvant (N) | 2014-04-24 | 2014-04-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025118 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003178 | 280007251 | 1.9 | 70 | Curative (C) | 2013-05-23 | 2013-06-04 | Cetuximab + Radiotherapy Load | N | Y | 280025124 | CETUXIMAB + RT |
| 280003179 | 280007251 | 1.75 | 106.2 | Neo-adjuvant (N) | 2010-10-07 | 2015-05-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025124 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003180 | 280007251 | 1.61 | 74.3 | null | null | 2017-05-04 | Cisplatin +Fluorouracil (3 wk) | null | null | 280025124 | CISPLATIN + FLUOROURACIL |
| 280003181 | 280007251 | 1.54 | 101.5 | Neo-adjuvant (N) | 2014-11-08 | 2014-11-22 | Doxorubicin + Ifosfamide | N | N | 280025124 | DOXORUBICIN + IFOSFAMIDE |
| 280003182 | 280002397 | 1.72 | 65.6 | Curative (C) | 2017-02-08 | 2017-03-06 | Cetuximab + Radiotherapy Load | N | Y | 280025136 | CETUXIMAB + RT |
| 280003183 | 280002398 | 1.7 | 89.9 | Curative (C) | 2018-01-28 | 2018-02-15 | CETUXIMAB + RT | 01 | Y | 280025137 | CETUXIMAB + RT |
| 280003184 | 280002398 | null | 81.2 | null | 2016-10-10 | 2016-10-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025137 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003185 | 280002398 | 1.75 | 60.6 | null | 2014-10-23 | 2014-11-05 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280025137 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003186 | 280002398 | 1.8 | 141 | Curative (C) | 2013-08-08 | 2013-08-08 | Cetuximab + Radiotherapy Load | N | N | 280025137 | CETUXIMAB + RT |
| 280003187 | 280002399 | 1.6 | 73.6 | Curative (C) | 2016-05-20 | 2016-07-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025143 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003188 | 280002399 | 1.82 | 0.1 | Curative (C) | null | 2015-12-07 | Cetuximab + Radiotherapy Load | null | null | 280025143 | CETUXIMAB + RT |
| 280003189 | 280002400 | 1.7 | 116.9 | Neo-adjuvant (N) | 2014-02-18 | 2014-02-22 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280025146 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003190 | 280002401 | 1.55 | 73.7 | Curative (C) | 2015-03-10 | 2015-03-10 | CETUXIMAB + RT | N | Y | 280025150 | CETUXIMAB + RT |
| 280003191 | 280007254 | null | 58.1 | Adjuvant (A) | 2015-10-30 | 2015-11-18 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025151 | DOXORUBICIN + IFOSFAMIDE |
| 280003192 | 280002402 | 1.61 | 50.5 | Neo-adjuvant (N) | 2015-05-16 | 2015-06-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025153 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003193 | 280002403 | 1.7 | 62 | null | 2017-10-01 | 2017-10-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025155 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003194 | 280002403 | null | 102 | Curative (C) | null | 2014-05-02 | Cetuximab + Radiotherapy Load | null | Y | 280025155 | CETUXIMAB + RT |
| 280003195 | 280002404 | 1.7 | 78 | null | 2015-09-21 | 2015-10-12 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025158 | DOXORUBICIN + IFOSFAMIDE |
| 280003196 | 280002405 | 1.8 | 94 | null | 2013-09-07 | 2013-09-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025159 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003197 | 280002406 | null | 95.5 | Curative (C) | 2013-11-27 | 2013-12-09 | Cetuximab + Radiotherapy Load | 2 | Y | 280025161 | CETUXIMAB + RT |
| 280003198 | 280002407 | 1.77 | 60 | Curative (C) | 2014-11-28 | 2014-12-02 | CISPLATIN + FLUOROURACIL | 02 | null | 280025164 | CISPLATIN + FLUOROURACIL |
| 280003199 | 280002408 | 0 | 98 | Adjuvant (A) | 2017-07-27 | 2017-08-03 | Doxorubicin + Ifosfamide | N | N | 280025165 | DOXORUBICIN + IFOSFAMIDE |
| 280003200 | 280007256 | null | 68.4 | Adjuvant (A) | 2015-04-02 | 2015-04-16 | CISPLATIN + FLUOROURACIL | null | N | 280025168 | CISPLATIN + FLUOROURACIL |
| 280003201 | 280002409 | 1.82 | 78.1 | Neo-adjuvant (N) | 2015-07-12 | 2015-07-23 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025171 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003202 | 280002410 | 1.67 | 79.4 | Curative (C) | 2017-05-13 | 2017-06-14 | CETUXIMAB + RT | N | Y | 280025173 | CETUXIMAB + RT |
| 280003203 | 280002411 | 1.7 | 102 | Neo-adjuvant (N) | 2013-02-24 | 2013-03-01 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 280025176 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003204 | 280002411 | 1.56 | 83 | Curative (C) | 2017-07-01 | 2017-07-18 | CETUXIMAB + RT | 02 | Y | 280025176 | CETUXIMAB + RT |
| 280003205 | 280009712 | 1.44 | 88.65 | Neo-adjuvant (N) | 2015-10-31 | 2015-11-04 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025178 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003206 | 280002412 | null | 78.8 | Curative (C) | null | 2016-08-08 | Cetuximab + Radiotherapy Load | null | null | 280025179 | CETUXIMAB + RT |
| 280003207 | 280002412 | 1.8 | 78.8 | null | 2017-09-10 | 2017-09-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025179 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003208 | 280002412 | 1.8 | 92.3 | Neo-adjuvant (N) | 2014-05-09 | 2014-05-09 | DOXORUBICIN + IFOSFAMIDE | N | N | 280025179 | DOXORUBICIN + IFOSFAMIDE |
| 280003209 | 280002413 | 1.55 | 93.5 | Neo-adjuvant (N) | 2015-06-17 | 2015-06-27 | Cisplatin + Docetaxel +Fluorouracil | null | N | 280025182 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003210 | 280002414 | 1.76 | 50.7 | Neo-adjuvant (N) | 2013-09-23 | 2013-09-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 280025184 | CISPLATIN + DOCETAXEL + FLUOROURACIL |